• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因子VIII/血管性血友病因子的二硫键与四级结构

Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.

作者信息

Counts R B, Paskell S L, Elgee S K

出版信息

J Clin Invest. 1978 Sep;62(3):702-9. doi: 10.1172/JCI109178.

DOI:10.1172/JCI109178
PMID:308512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC371817/
Abstract

Human Factor VIII/von Willebrand factor, purified by calcium citrate-cellulose chromatography and 4% agarose gel filtration was subjected to sodium dodecyl sulfate gel electrophoresis on gels containing 2% acrylamide and 0.5% agarose. We find a series of multimers of which the apparent molecular weight of the higher members was congruent with5 million. The higher multimers were isolated by 2% agarose gel filtration. Treatment of the high molecular weight multimers with 2-mercaptoethanol at concentrations of 0.005-0.5% in the presence of 1% dodecyl sulfate resulted in a shift to lower molecular weight multimers. Between mercaptoethanol concentrations of 0.01 and 0.5%, the predominant species was the dimer of the basic subunit. Mercaptoethanol concentrations >0.5% were required to reduce the interchain disulfide bonds of the dimer. An artificial multimeric series was prepared by cross-linking von Willebrand factor subunits with dimethylsuberimidate. Comparison of the multimers produced by reduction with the multimers produced by cross-linking, demonstrated the absence of odd-numbered multimers from the reduced series. Thus, the protomeric unit appears to be the dimer. High molecular weight multimers had both ristocetin cofactor activity and Factor VIII procoagulant activity. Reduction of the protein in the absence of denaturing agents, caused a gradual shift to lower molecular weight species and a concomitant loss of von Willebrand factor activity. In contrast, Factor VIII activity was unchanged by reduction. These studies suggest that the moieties having von Willebrand factor activity and those having Factor VIII activities are covalently linked by disulfide bonds.

摘要

通过柠檬酸钙 - 纤维素色谱法和4%琼脂糖凝胶过滤纯化的人因子VIII/血管性血友病因子,在含有2%丙烯酰胺和0.5%琼脂糖的凝胶上进行十二烷基硫酸钠凝胶电泳。我们发现了一系列多聚体,其中较高分子量成员的表观分子量与500万一致。通过2%琼脂糖凝胶过滤分离出较高的多聚体。在1%十二烷基硫酸钠存在下,用浓度为0.005 - 0.5%的2 - 巯基乙醇处理高分子量多聚体,导致向较低分子量多聚体转变。在巯基乙醇浓度为0.01%至0.5%之间,主要物种是基本亚基的二聚体。需要巯基乙醇浓度>0.5%才能还原二聚体的链间二硫键。通过用亚胺基二甲酯交联血管性血友病因子亚基制备了人工多聚体系列。将还原产生的多聚体与交联产生的多聚体进行比较,表明还原系列中不存在奇数多聚体。因此,原聚体单元似乎是二聚体。高分子量多聚体同时具有瑞斯托霉素辅因子活性和因子VIII促凝血活性。在不存在变性剂的情况下还原蛋白质,导致逐渐向较低分子量物种转变,并伴随血管性血友病因子活性丧失。相比之下,因子VIII活性不受还原影响。这些研究表明,具有血管性血友病因子活性的部分和具有因子VIII活性的部分通过二硫键共价连接。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b01/371817/e0451800a9d1/jcinvest00669-0204-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b01/371817/ff37eaf6e175/jcinvest00669-0203-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b01/371817/e3a3782000a4/jcinvest00669-0203-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b01/371817/7b47d63d8fd6/jcinvest00669-0204-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b01/371817/e0451800a9d1/jcinvest00669-0204-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b01/371817/ff37eaf6e175/jcinvest00669-0203-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b01/371817/e3a3782000a4/jcinvest00669-0203-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b01/371817/7b47d63d8fd6/jcinvest00669-0204-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b01/371817/e0451800a9d1/jcinvest00669-0204-b.jpg

相似文献

1
Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.因子VIII/血管性血友病因子的二硫键与四级结构
J Clin Invest. 1978 Sep;62(3):702-9. doi: 10.1172/JCI109178.
2
Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.人类抗血友病因子的研究。共价连接亚基结构的证据。
J Clin Invest. 1976 Apr;57(4):925-37. doi: 10.1172/JCI108369.
3
Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.低分子量人凝血因子VIII的血管性血友病因子活性通过与金颗粒结合而增加。
Thromb Haemost. 1981 Jun 30;45(3):242-6.
4
Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.钙对凝血酶激活人凝血因子VIII/血管性血友病因子蛋白的某些影响。
J Clin Invest. 1977 Oct;60(4):819-28. doi: 10.1172/JCI108836.
5
Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.血管性血友病:通过分析血浆和血小板中因子VIII/血管性血友病因子的多聚体组成来鉴定两种亚型
J Clin Invest. 1980 Jun;65(6):1318-25. doi: 10.1172/JCI109795.
6
Purification of porcine and human ristocetin-Willebrand factor.猪和人瑞斯托菌素-血管性血友病因子的纯化
J Lab Clin Med. 1977 Jun;89(6):1278-94.
7
[Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules].[低分子量因子VIII与金颗粒结合后血管性血友病因子活性增加]
Schweiz Med Wochenschr. 1980 Oct 4;110(40):1456-8.
8
Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease.血管性血友病中因子VIII/血管性血友病因子的多聚体结构
J Lab Clin Med. 1980 Apr;95(4):590-602.
9
Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.凝血因子VIII/血管性血友病因子蛋白。半乳糖是血管性血友病因子活性的一个隐蔽决定因素。
J Clin Invest. 1978 Aug;62(2):496-9. doi: 10.1172/JCI109152.
10
Multimers of von Willebrand antigen in therapeutic factor VIII concentrates.治疗性凝血因子VIII浓缩物中血管性血友病因子抗原多聚体
Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(6):831-40.

引用本文的文献

1
Conformation-dependent blockage of activated VWF improves outcomes of traumatic brain injury in mice.构象依赖性阻断激活的 VWF 可改善创伤性脑损伤小鼠的预后。
Blood. 2021 Jan 28;137(4):544-555. doi: 10.1182/blood.2020007364.
2
Multimerin 1 supports platelet function in vivo and binds to specific GPAGPOGPX motifs in fibrillar collagens that enhance platelet adhesion.多聚体蛋白1在体内支持血小板功能,并与纤维状胶原蛋白中的特定GPAGPOGPX基序结合,增强血小板黏附。
J Thromb Haemost. 2021 Feb;19(2):547-561. doi: 10.1111/jth.15171. Epub 2020 Dec 17.
3
Diverse activities of von Willebrand factor in traumatic brain injury and associated coagulopathy.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.高岭土部分凝血活酶时间。用于筛查第一阶段血浆凝血因子缺乏症的简单检测。
Am J Clin Pathol. 1961 Sep;36:212-9. doi: 10.1093/ajcp/36.3.212.
3
Tissue sulfhydryl groups.组织巯基
血管性血友病因子在创伤性脑损伤及相关凝血病中的多种作用
J Thromb Haemost. 2020 Dec;18(12):3154-3162. doi: 10.1111/jth.15096. Epub 2020 Oct 6.
4
Acquired von Willebrand syndrome associated with left ventricular assist device.与左心室辅助装置相关的获得性血管性血友病综合征
Blood. 2016 Jun 23;127(25):3133-41. doi: 10.1182/blood-2015-10-636480. Epub 2016 May 3.
5
A common variant in the Von Willebrand factor gene is associated with multiple functional consequences.常见的血管性血友病因子基因突变与多种功能后果相关。
Am J Hematol. 2010 Dec;85(12):971-3. doi: 10.1002/ajh.21859.
6
Subunit structure and assembly of von Willebrand factor polymer: complementary analysis by electron microscopy and quasielastic light scattering.血管性血友病因子聚合物的亚基结构与组装:电子显微镜和准弹性光散射的互补分析
Biophys J. 1986 Jan;49(1):49-50. doi: 10.1016/S0006-3495(86)83588-3.
7
Control of von Willebrand factor multimer size by thrombospondin-1.血小板反应蛋白-1对血管性血友病因子多聚体大小的调控
J Exp Med. 2001 Jun 18;193(12):1341-9. doi: 10.1084/jem.193.12.1341.
8
Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers.血管性血友病因子的三联体结构反映了高分子量多聚体的蛋白水解降解。
Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7503-7. doi: 10.1073/pnas.90.16.7503.
9
Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC).血管性血友病(IIC型)新变体中血管性血友病因子的异常多聚体结构。
J Clin Invest. 1982 Nov;70(5):1124-7. doi: 10.1172/jci110700.
10
Electron microscopy of human factor VIII/Von Willebrand glycoprotein: effect of reducing reagents on structure and function.人凝血因子VIII/血管性血友病糖蛋白的电子显微镜观察:还原剂对其结构和功能的影响
J Cell Biol. 1982 Nov;95(2 Pt 1):632-40. doi: 10.1083/jcb.95.2.632.
Arch Biochem Biophys. 1959 May;82(1):70-7. doi: 10.1016/0003-9861(59)90090-6.
4
A brain extract as a substitute for platelet suspensions in the thromboplastin generation test.在凝血活酶生成试验中,用脑提取物替代血小板悬液。
Nature. 1954 Nov 6;174(4436):880-1. doi: 10.1038/174880a0.
5
Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.抗血友病因子对一期凝血试验的影响;血友病的一种推定试验及一种简单的一期抗血友病因子测定方法。
J Lab Clin Med. 1953 Apr;41(4):637-47.
6
Disulfide-bond cleavage and formation in proteins.蛋白质中二硫键的断裂与形成
Science. 1965 Dec 17;150(3703):1595-8. doi: 10.1126/science.150.3703.1595.
7
Thiol groups in the blood clotting action of factor VIII.因子VIII凝血作用中的巯基。
Br J Haematol. 1970 Oct;19(4):477-84. doi: 10.1111/j.1365-2141.1970.tb06975.x.
8
Separation of sub-units of antihemophilic factor (AHF) by agarose gel chromatography.通过琼脂糖凝胶色谱法分离抗血友病因子(AHF)的亚基。
Thromb Diath Haemorrh. 1972 Apr 30;27(2):212-9.
9
Use of dimethyl suberimidate, a cross-linking reagent, in studying the subunit structure of oligomeric proteins.使用交联试剂辛二酸二甲酯亚胺来研究寡聚蛋白的亚基结构。
Proc Natl Acad Sci U S A. 1970 Jul;66(3):651-6. doi: 10.1073/pnas.66.3.651.
10
Molecular weight estimation and separation of ribonucleic acid by electrophoresis in agarose-acrylamide composite gels.在琼脂糖-丙烯酰胺复合凝胶中通过电泳进行核糖核酸的分子量估计及分离
Biochemistry. 1968 Feb;7(2):668-74. doi: 10.1021/bi00842a023.